EBERNET CREAM
EBERCONAZOLE NITRATE
What it does
Eberconazole is a medicine used to treat fungal skin infections.
Commonly used for: fungal skin infections, tinea (ringworm), athlete's foot (tinea pedis), skin candidiasis
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:57:55 · updated 2026-10-20 02:29:24
About this medicine
Eberconazole is a medicine used to treat fungal skin infections.
What it treats
- fungal skin infections
- tinea (ringworm)
- athlete's foot (tinea pedis)
- skin candidiasis
How it works
Eberconazole works by stopping the growth of fungi, helping to clear up infections.
Who it's for
This medicine is for adults and children with fungal skin infections.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: eberconazole
BNF-referencedEberconazole is a topical antifungal medication belonging to the azole class. It is primarily used to treat skin infections caused by fungi, including dermatophytes and yeasts. Eberconazole works by inhibiting the growth of fungi, providing effective relief from fungal infections.
Indications
- Dermatophyte infections
- Yeast infections
- Tinea corporis
- Tinea pedis
- Tinea cruris
Dosage
Children: For pediatric dosing, refer to BNF for Children for appropriate guidelines.
Adults: For adults, the recommended dosage and application instructions should be adhered to as specified in the prescribing information or BNF.
Mechanism of action
Eberconazole shares a mechanism of action with other antimycotic azoles: It inhibits lanosterol 14a-demethylase, thereby blocking the synthesis of precursors of ergosterols, which are essential components of fungal cell membranes.
Pharmacodynamics
Eberconazole is active against Gram-positive bacteria, dermatophytes, and yeasts. Its antifungal properties stem from its ability to disrupt the synthesis of ergosterol, leading to impaired cell membrane integrity and function in susceptible fungi.
Pharmacokinetics
The pharmacokinetics of eberconazole involve topical application, leading to localized effects with minimal systemic absorption. As a result, adverse effects are generally limited. Specific pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion have not been extensively detailed in available literature.
Pregnancy
Eberconazole should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult relevant guidelines for specific recommendations.
Breast-feeding
Eberconazole should be used with caution in breastfeeding. Consult relevant guidelines for specific recommendations.
Storage
Store at room temperature, away from moisture and heat. Keep out of reach of children.
Formulations
- Topical cream
- Topical solution
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: eberconazole
PubChem CID 72051Molecular formula: C18H14Cl2N2
Mechanism of action
Eberconazole shares a mechanism of action with other antimycotic azoles: It inhibits lanosterol 14a-demethylase, thereby blocking the synthesis of precursors of ergosterols.
Pharmacodynamics
Eberconazole is active against Gram-positive bacteria, dermatophytes, and yeasts.
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.